Treatment-Resistant Depression: An Update on Management Strategies-Presentation Slides

Presentation Slides

Pdf Summary

This document is a transcript or summary of a webinar on the topic of treatment-resistant depression. The webinar is part of the Clinical Support System for Serious Mental Illness (CSS-SMI) initiative, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and implemented by the American Psychiatric Association (APA). The webinar covers various aspects of treatment-resistant depression, including risk factors, management strategies, and different treatment options. Some of the treatment strategies discussed include pharmacological augmentation, neuromodulation techniques such as transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), as well as the use of ketamine or esketamine. The document also provides information on the safety and potential side effects of these treatment approaches, and mentions the need for careful evaluation and monitoring of patients undergoing these treatments. Overall, the webinar aims to provide healthcare professionals with a current update on management strategies for treatment-resistant depression.

Keywords

treatment-resistant depression

webinar

management strategies

pharmacological augmentation

neuromodulation techniques

transcranial magnetic stimulation

electroconvulsive therapy

ketamine

esketamine

healthcare professionals